Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Introduction. Search strategy.

Safety 52

Safety Cannabinoids Events Data 52

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. Following the treatment period, there was a 35.5% Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. And as long as the healthcare provider in charge judges the infusion therapy to be ethical and not violative of safety standards, they may prescribe it accordingly.

Therapy 101

Therapy Legalization Chronic Pain DEA 101

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

JUNE 17, 2021

To get a well-balanced and effective treatment without any side effects, you should consider CBD oil. Neurological Disorders: In addition to neurological illnesses, CBD is being investigated for treatment. In addition to FDA regulations not governing these products, their safety cannot be assured by standard labeling or certification.

Oil 104

Oil CBD Therapy Treatment 104

Cannabis Chronicles

JUNE 27, 2019

Most recently, the store opened in 2017 after being granted a reprieve while it challenged the ban in court. In April, the council held a work session examining the public safety and health aspects of legal cannabis. But after losing the appeal, John Larson was ordered in March to pay a civil penalty of $112,500 to the county.

Law 113

Law Retail State Laws Business 113

CannaMD

MARCH 3, 2021

Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Does access to marijuana result in an increase in violent crimes over state lines, or does it lessen crime and bolster public safety? Find Out if You Qualify. Get Started.

Legalization 119

Legalization Marijuana Data Safety 119

Veriheal

FEBRUARY 28, 2022

The need for effective treatment is not only important for restoring one’s health but also for returning functioning and quality of life. A New Kind of Depression Treatment. In 2017, Sheng was a co-author for a study on the crystal structure of an LSD -bound human serotonin receptor. In 2019, the U.S.

Research and Development 98

Research and Development Treatment Therapy Environment 98

Veriheal

NOVEMBER 30, 2021

For the first time in over 50 years, a federal grant has been allocated for studying psychedelic treatment. In 2008, he published psychedelic safety guidelines. He conducted the first blinded human research study into the psychoactive effects of salvinorin A in 2011 and published data on MDMA pill testing services in 2017.

Research and Development 98

Research and Development Therapy Data Treatment 98

TheAnswerPage

JULY 17, 2022

In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.

Epilepsy 56

Epilepsy Extraction Treatment CBD 56

MJ Business Attorneys

OCTOBER 26, 2017

July 5, 2017. She came to the industry not from the recreational side, but as a mother seeking treatment for her child with epilepsy. I had taken her to the top two pediatric neurologists in Houston and I was given conflicting diagnoses, conflicting treatment plans. Is it inherently Texan to legalize marijuana?

Epilepsy 100

Epilepsy Recreational Treatment Programs 100

Cannabis Law Report

JUNE 7, 2021

The special retail tax rate was 10% until the legislature and governor increased it in July 2017. Also, until July 2017, a 2.9% Of the cannabis-related tax revenue it collects, the state distributes 40% to public schools, 15% to law enforcement, and 25% to mental health and treatment programs. million as of April 2021.

Marijuana 91

Marijuana Retail Collective Programs 91

Project CBD

FEBRUARY 28, 2023

CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Medical cannabinoids for treatment of neuropsychiatric symptoms in dementia: A systematic review. increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. times more likely. times more likely.

Marijuana 105

Marijuana Education Advocacy Legislation 105

CannaMD

JANUARY 5, 2021

Canada has been carrying out annual surveys to assess the results of participants in their nation’s medical marijuana program since 2017. To stay up-to-date with the latest studies and legal regulations surrounding medical marijuana treatment, be sure to follow CannaMD on Facebook and sign up for our newsletter, below! Get Started.

Patients 105

Patients Consumption Cannabis Marijuana 105

The Cannigma

JUNE 16, 2022

A randomized, double-blinded, crossover trial tested the safety and efficacy of sublingual cannabis dosing in 23 people with insomnia. 6 A 2017 review of research concluded that CBD may have “therapeutic potential” for people with insomnia at lower doses. Easing insomnia. Issues with cannabis consumption in seniors.

Terpenes 101

Terpenes Strains Sleep THC 101

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Otherside Farms

DECEMBER 10, 2019

CBD is additionally being investigated as an available treatment for pain, anxiety, and schizophrenic psychosis symptoms in humans. The safety and risks of CBD for dogs haven’t but been researched. CBD, in its pure state, seems to be safe and well-tolerated by animals, in line with a 2017 World Health Organization report.

Oil 18

Oil CBD Pets Blood Pressure 18

Cannabis Law Report

JUNE 20, 2019

The court declared President Duque’s Police Code unconstitutional and a violation of citizens’ constitutional rights, despite arguments that many of its provisions existed to protect the public safety of children. Present law allows each Colombian household to grow up to 20 plants; sales and purchases remain illegal. …/.

Consumption 61

Consumption Safety Treatment Policy 61

SpeedWeed

SEPTEMBER 18, 2021

Still About Safety. Two and a half years since the passage of the 2018 Farm Bill, the FDA’s recent refusals make clear that the agency has unresolved safety concerns. In prior instances, though, the FDA’s refusal rationale was limited to the drug preclusion language, likely because prior petitions failed to include safety data.

Data 79

Data Safety Food Pets 79

The Joint Blog

JUNE 28, 2019

According to new research, the use of marijuana is a safe and effective treatment for those with fibromyalgia. The study, titled Safety and efficacy of medical cannabis in fibromyalgia, was published by the Journal of Clinical Medicine and was published online by the U.S. 0.72), concerns about cannabis treatment (OR 0.36, 95% C.I

Therapy 44

Therapy Chronic Pain Treatment Marijuana 44

The Joint Blog

JUNE 2, 2020

The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. Pain intensity and safety parameters were recorded on a 10-cm visual analogue scale (VAS) at pre-defined time points.

Chronic Pain 58

Chronic Pain Clinical Trials Marijuana Safety 58

MMJ Recs

APRIL 11, 2024

West Virginia has emerged as a trailblazer in the realm of medical marijuana, implementing a comprehensive program to provide patients with access to this therapeutic treatment option. By adhering to strict regulatory standards, West Virginia aims to safeguard patient health and ensure the quality and safety of medical cannabis products.

Law 52

Law Programs Patients Conditions 52

Healer

APRIL 5, 2021

The available research on CBD for pain in humans includes: In a mixed cohort of 24 patients suffering from intractable pain due to multiple sclerosis, spinal cord injury, brachial plexus injury, and limb amputation, CBD treatment (average 22 mg daily, max 60 mg daily) significantly reduced pain on a visual analog scale.[2].

CBD 98

CBD Chronic Pain Oil Topical 98

Alchimia

FEBRUARY 1, 2022

Neuroprotective : could contribute to the treatment of neurodegenerative diseases such as multiple sclerosis. To date, there are several studies that have tried to verify the safety and toxicology of CBD when it is administered to treat certain diseases. What are the side effects of CBD? Drowsiness. Reduced appetite/weight changes.

CBD 52

CBD Epilepsy Research and Development Cannabinoids 52

Veriheal

NOVEMBER 10, 2020

Despite the fact that there are still months before the start of this experiment, Nicolas Authier (chair of the French Agency for Safety of Medicines and Health Products, or ANSM) stated that France is now officially committed to giving citizens access to medical cannabis. .

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

Cannabis Law Report

JULY 1, 2021

In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression. These developments indicate that psychedelics may represent substantial improvements over existing treatments for mental illness.

Law 59

Law Policy Research and Development Clinical Trials 59

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 88

Marijuana Therapy Data THC 88

LifeCannMD

AUGUST 2, 2024

Medical Marijuana is increasingly being considered as a potential treatment for severe migraines. More clinical trials are needed to establish definitive efficacy and safety profiles. If you have chronic migraines, you should consult with Dr. Fernando Fandiño-Sende to obtain a medical marijuana card and begin treatment.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

MMJ Recs

JUNE 9, 2024

West Virginia’s medical marijuana program was established to provide patients with qualifying medical conditions access to medical cannabis as an alternative treatment option. The program was enacted into law in April 2017 with the passage of the West Virginia Medical Cannabis Act.

Access 52

Access Marijuana Patients Programs 52

SpeedWeed

SEPTEMBER 20, 2021

Still About Safety. Two and a half years since the passage of the 2018 Farm Bill, the FDA’s recent refusals make clear that the agency has unresolved safety concerns. In prior instances, though, the FDA’s refusal rationale was limited to the drug preclusion language, likely because prior petitions failed to include safety data.

Business 60

Business Data Safety Food 60

SpeedWeed

SEPTEMBER 17, 2021

Still About Safety. Two and a half years since the passage of the 2018 Farm Bill, the FDA’s recent refusals make clear that the agency has unresolved safety concerns. In these most recent refusals, however, the agency had safety data to review. This is not the first time that the FDA has responded to an NDIN regarding CBD.

CBD 61

CBD Data Safety Food 61

Cannabis Law Report

MARCH 6, 2020

” In 2018, Europe was responsible for 23.2% of the world’s pharmaceutical sales with the size of the market in the EU-5 ( United Kingdom , Germany , Spain , France , and Italy ) set to grow by 25% between 2017 and 2022. It’s safety and efficacy have not been confirmed by FDA-approved research.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

MMJ Recs

OCTOBER 13, 2023

For patients seeking access to this valuable form of treatment, it’s essential to understand the complex web of regulations, legal requirements, and rights surrounding medical marijuana in the Golden State. California has long been a pioneer in the field of medical marijuana, and its MMJ laws have continued to evolve over the years.

Patients 52

Patients Law Cultivation Dispensary 52

Healer

DECEMBER 17, 2021

The safety profile of CBD has been acknowledged by major health agencies, such as the World Health Organization (WHO), showing that it’s well-tolerated by animals and humans and rarely produces any dangerous side effects. Some compounds work synergistically with CBD, so asking your doctor can help you maximize the effect of your treatment.

CBD 98

CBD THC Conditions Medicine 98

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. where patients are legally administered ketamine for treatment of mental illness and severe pain.

Law 81

Law Therapy Clinical Trials Research and Development 81